Skip to content

To understand the relation between doshanubandhit amavata and markers of inflammation

A Diagnostic evalution to correlate classical lakshanas and Inflammatory markers in Doshanubandhit Amavata - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084563
Enrollment
30
Registered
2025-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

None listed

Sponsors

Dr Aastha Jain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Subjects irrespective of gender, caste, occupation and socio economic conditions. b) Subjects between the age group of 18 70 years. c) Subjects with known case of Amavata and presenting with the classical features of Doshanubandhit Amavata according to Ayurveda textual criteria.

Exclusion criteria

Exclusion criteria: a) Chronicity of Amavata more than 03 years. b) Patient taking steroids from past 3 months. c) Patients suffering from other autoimmune disorders. d) Patient taking analgesic injections at painful site. e) Any systemic illness intervenes the study.

Design outcomes

Primary

MeasureTime frame
To assess the diagnostic value of classical ayurvedic symptoms in Amavata and correlate them with laboratory Inflammatory markers to enhance integrative diagnosis accuracy.Timepoint: a) Chronicity of Amavata patient more than 03 years. b) Day 1: Patient Consent Enrolled and sample collection. c) Week 1 - Assesment of Lakshanas with Inflammatory markers.

Secondary

MeasureTime frame
It will act as a baseline study to enhance the integrative diagnosis of Amavata in association to inflammatory markersTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Prashant Patil

Parul Institute of Ayurved and Research, Vadodara, Gujarat

dr.prashantpatil17@gmail.com7972675677

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026